Rafik Terra

He holds a doctorate in biomedical sciences/immunology and a post-doctoral degree in the field of transplantation. He did additional training in multicolour flow cytometry to standardize diagnoses of hematological malignancies, including multiple myeloma, with Euroflow. Since 2009, he has served as an executive in quality of hematology laboratories for Hôpital Maisonneuve-Rosemont and as scientific director of the clinical immunology laboratory. He is in charge of post-treatment assessment of minimal residual disease for multiple myeloma.

«  See the other members of the team